←Back to Expert Scholars
Translational Medicine / 转化医学STING Pathway, Tumor Immunology
Thomas Gajewski
MD, PhD
🏢University of Chicago🌐USA
Professor of Pathology and Medicine
105
h-index
0
Key Papers
0
Key Contributions
👥Biography 个人简介
Thomas Gajewski identified the T-cell-inflamed versus non-inflamed tumor phenotype and linked STING activation to spontaneous anti-tumor immunity. His laboratory drives STING agonist development for converting non-inflamed tumors. He is a leading voice in understanding mechanisms of T cell exclusion.
Share:
🧪Research Fields 研究领域
STING agonist
cGAS-STING
T cell inflamed tumors
microbiome immunotherapy
non-T cell inflamed phenotype
🎓Key Contributions 主要贡献
Representative Works 代表性著作
📄Data Sources 数据来源
Last updated: 2026-04-01 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Melanoma ImmunotherapyCheckpoint Inhibitors
Drew M. Pardoll
Johns Hopkins University
Cancer ImmunologyPD-1/PD-L1 Pathway
Padmanee Sharma
MD Anderson Cancer Center
Bladder Cancer ImmunotherapyImmune Profiling
Naiyer A. Rizvi
Columbia University Irving Medical Center
Lung Cancer ImmunotherapyTumor Mutational Burden
关注 Thomas Gajewski 的研究动态
Follow Thomas Gajewski's research updates
留下邮箱，当我们发布与 Thomas Gajewski（University of Chicago）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment